Pennant Group, Inc. (PNTG) stock
PNTGNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/307% above fair value
$35.81−0.69 (-1.89%)
Close on Nov 18, 2026Market cap $1.25BP/E 39.8Yield –
Pennant revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pennant's revenue for the twelve months ending Jun 30, 2026 was $1.10B, up 37.9% year over year. For fiscal 2025 it was $947.71M, up 36.3% from the year before. The highest annual figure on record is $947.71M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $947.71M | +36.3% |
| FY2024 | Dec 31, 2024 | $695.24M | +27.6% |
| FY2023 | Dec 31, 2023 | $544.89M | +15.1% |
| FY2022 | Dec 31, 2022 | $473.24M | +7.6% |
| FY2021 | Dec 31, 2021 | $439.69M | +12.5% |
| FY2020 | Dec 31, 2020 | $390.95M | +15.5% |
| FY2019 | Dec 31, 2019 | $338.53M | +18.3% |
| FY2018 | Dec 31, 2018 | $286.06M | +14.0% |
| FY2017 | Dec 31, 2017 | $250.99M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $297.98M | +35.8% |
| Q1 FY2026 | Mar 31, 2026 | $285.36M | +36.0% |
| Q4 FY2025 | Dec 31, 2025 | $289.32M | +53.2% |
| Q3 FY2025 | Sep 30, 2025 | $229.04M | +26.8% |
| Q2 FY2025 | Jun 30, 2025 | $219.50M | +30.1% |
| Q1 FY2025 | Mar 31, 2025 | $209.84M | +33.7% |
| Q4 FY2024 | Dec 31, 2024 | $188.89M | +29.4% |
| Q3 FY2024 | Sep 30, 2024 | $180.69M | +28.9% |
| Q2 FY2024 | Jun 30, 2024 | $168.75M | +27.6% |
| Q1 FY2024 | Mar 31, 2024 | $156.92M | +24.1% |
| Q4 FY2023 | Dec 31, 2023 | $145.95M | +17.1% |
| Q3 FY2023 | Sep 30, 2023 | $140.19M | +18.5% |
| Q2 FY2023 | Jun 30, 2023 | $132.28M | +13.7% |
| Q1 FY2023 | Mar 31, 2023 | $126.46M | +11.0% |
| Q4 FY2022 | Dec 31, 2022 | $124.67M | +11.5% |
| Q3 FY2022 | Sep 30, 2022 | $118.35M | +5.7% |
| Q2 FY2022 | Jun 30, 2022 | $116.32M | +5.4% |
| Q1 FY2022 | Mar 31, 2022 | $113.91M | +7.8% |
| Q4 FY2021 | Dec 31, 2021 | $111.77M | +3.5% |
| Q3 FY2021 | Sep 30, 2021 | $111.92M | +13.7% |
| Q2 FY2021 | Jun 30, 2021 | $110.35M | +19.0% |
| Q1 FY2021 | Mar 31, 2021 | $105.66M | +15.0% |
| Q4 FY2020 | Dec 31, 2020 | $107.97M | +20.6% |
| Q3 FY2020 | Sep 30, 2020 | $98.40M | +11.3% |
| Q2 FY2020 | Jun 30, 2020 | $92.74M | +12.1% |
| Q1 FY2020 | Mar 31, 2020 | $91.85M | +17.9% |
| Q4 FY2019 | Dec 31, 2019 | $89.49M | +18.8% |
| Q3 FY2019 | Sep 30, 2019 | $88.40M | +21.2% |
| Q2 FY2019 | Jun 30, 2019 | $82.73M | – |
| Q1 FY2019 | Mar 31, 2019 | $77.91M | – |
| Q4 FY2018 | Dec 31, 2018 | $75.34M | – |
| Q3 FY2018 | Sep 30, 2018 | $72.95M | – |
See a number that looks wrong?